Aids Arms Inc

1. Gilead Sciences, Inc. $995,737 192 payments
2. ViiV Healthcare Company $461,517 40 payments
3. AbbVie, Inc. $148,865 31 payments
4. Janssen Research & Development, LLC $58,569 25 payments
5. Evofem Biosciences, Inc. $29,293 17 payments

1. A Qualitative Hybrid III Implementation Study to Identify and Evaluate $247,847 13 payments
2. A Phase III, Randomized, Multicenter, Parallel-Group, Non-Inferiority $136,735 16 payments
3. A Phase Iiib, Randomized, Multicenter, Active-Controlled, Parallel-Gro $76,935 11 payments
4. A Phase 4 Randomized Active Controlled Open label Study to Evaluate the Safety and Tolerability of Switching to Once Daily Darunavir Cobicistat Emtricitabine Tenofovir Alafenamide DCFTAF Fixed dose Combination FDC Regimen in Virologically suppressed Human $37,027 13 payments
5. A Phase 1b Randomized, Double-Blinded, Placebo Controlled, Multi-Cohort Study of the Safety, Pharmacokinetics, and Antiviral Activity of GS-6207 Administered Subcutaneously in HIV-1 Infected Subjects $34,907 1 payment
6. A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection $34,682 1 payment
7. A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection $32,153 1 payment
8. A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection $28,275 1 payment
9. M19-939 $27,463 3 payments
10. A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection $26,989 1 payment

1. Professional salary support $25,814 16 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.